MO2-5-6Palbociclib (PAL) + cetuximab (CET) vs CET in patients (pts) with head and neck cancer: Asian subgroup analysis
Tahara, Makoto, Lin, Jin Ching, Sacco, Assuntina, Ley, Jessica, Oppelt, Peter, Shen, Qi, Kern, Kenneth, Thurm, Holger, Wang, Shaw Ling, Martini, Jean Francois, Hoffman, Justin, Melichar, Bohuslav, AdkVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz338.056
Date:
October, 2019
File:
PDF, 78 KB
english, 2019